Validation of the “Brief Symptom Checklist” (LSB-50) instrument for the management of addictions

Authors

DOI:

https://doi.org/10.62452/093rzv40

Keywords:

Validation study, psychometrics, behavior addictive

Abstract

Addictions are complex disorders that affect mental health and require effective tools for psychopathological assessment. The Brief Symptom List (LSB-50) is an instrument designed to evaluate psychological and psychosomatic symptoms in the Madrid context. The present study aimed to validate the LSB-50 for use in the management of addictions at the Psychiatric Hospital of Havana. In a first qualitative phase, through interviews with experts and the Delphi method, the content and construct of the instrument were validated. In a second quantitative phase, a pilot test was conducted with 27 patients, assessing the clarity and reliability of the instrument, which demonstrated remarkable internal consistency, supported by a Cronbach's Alpha coefficient of 0,89. The results suggest that the LSB-50 is useful for identifying psychological and psychosomatic symptoms in patients with addictions, enhancing therapeutic intervention due to its content validity, construct validity, and reliability.

Downloads

Download data is not yet available.

Author Biographies

  • Yasmianis Ramírez-López, Universidad de Ciencias Médicas de La Habana. Cuba.

     

     

  • Ivis Yania Piovet-Hernández, Universidad Bolivariana. Ecuador.

     

     

  • Serguei Iglesias-Moré, Universidad de Ciencias Médicas de La Habana. Cuba.

     

     

References

Asociación Americana de Psiquiatría. (2014). Manual diagnóstico y estadístico de los trastornos mentales (DSM-5) (5ta Ed.). Editorial Médica Panamericana.

Beck, A. T. (1967). Depression: Clinical, Experimental and Theoretical Aspects. In Harper & Row.

Contreras Olive, Y., Miranda Gómez, O., & Torres Lio-Coo, V. (2020). Ansiedad y depresión en pacientes adictos a sustancias psicoactivas. Revista Cubana de Medicina Militar, 49(1), 71–85. https://revmedmilitar.sld.cu/index.php/mil/article/view/492/449

De La Iglesia, G., Stover, J. B., Castro Solano, A., & Fernández-Liporace, M. (2015). Validez de constructo del LSB-50 en adultos argentinos: Validación cruzada e invarianza factorial. Acción Psicológica, 12(2), 43–58. https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1578-908X2015000200004

De Rivera, L., & Abuín, M. R. (2012). LSB-50. Listado de síntomas breve. Tea Ediciones.

Engel, G. L. (1977). The Need for a New Medical Model: A Challenge for Biomedicine. Science, 196(4286), 129–136. https://pubmed.ncbi.nlm.nih.gov/847460/

Ferreira García, E., & Calderón Garrido, C. (2022). Evaluación de Adultos: LSB-50. Evaluación de síntomas psicológicos. Universidad de Barcelona. https://diposit.ub.edu/dspace/bitstream/2445/186246/4/LSB-50_Evaluacion%20de%20sintomas%20psicologicos_2.pdf

Landis, R., & Koch, G. (1977). The Measurement of Observer Agreement for Categorical Data. Biometrics, 33(1), 159–174. https://pubmed.ncbi.nlm.nih.gov/843571/

Organización de las Naciones Unidas. (2022). World Drug Report 2022. United Nations Publication. http://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html

Verdejo-García, A. (2016). Evaluación neuropsicológica en adicciones: Guía clínica. Acción Psicológica, 13(1), 1–6. https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1578-908X2016000100001

Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. N Engl J Med, 374, 363–371. https://doi.org/10.1056/NEJMra15114

Downloads

Published

2025-04-01

How to Cite

Ramírez-López, Y. ., Rodríguez-Larraburu, E. ., Piovet-Hernández, I. Y. ., Iglesias-Moré, S. ., & Fabelo-Roche, J. R. . (2025). Validation of the “Brief Symptom Checklist” (LSB-50) instrument for the management of addictions. Revista Metropolitana De Ciencias Aplicadas, 8(2), 202-211. https://doi.org/10.62452/093rzv40